{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:10:19Z","timestamp":1790140219420,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.ejphar.2011.09.171","type":"journal-article","created":{"date-parts":[[2011,9,29]],"date-time":"2011-09-29T18:00:52Z","timestamp":1317319252000},"page":"441-447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Preventive and therapeutic effects of caffeic acid against inflammatory injury in striatum of MPTP-treated mice"],"prefix":"10.1016","volume":"670","author":[{"given":"Shih-jei","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Che-yi","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-chin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2011.09.171_bb0005","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1523\/JNEUROSCI.21-17-06853.2001","article-title":"Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease","volume":"21","author":"Bezard","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2011.09.171_bb0170","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1743-7075-6-33","article-title":"Anti-inflammatory and anti-coagulatory activities of caffeic acid and ellagic acid in cardiac tissue of diabetic mice","volume":"6","author":"Chao","year":"2009","journal-title":"Nutr. Metab. (Lond)"},{"key":"10.1016\/j.ejphar.2011.09.171_bb0015","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0161-813X(02)00079-7","article-title":"Prevention of nitric oxide-mediated 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine-induced Parkinson's disease in mice by tea phenolic epigallocatechin 3-gallate","volume":"23","author":"Choi","year":"2002","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.ejphar.2011.09.171_bb0020","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1523-1755.2000.00808.x","article-title":"Nitric oxide modulates expression of matrix metalloproteinase-9 in rat mesangial cells","volume":"57","author":"Eberhardt","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2011.09.171_bb0025","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1471-4159.2004.02399.x","article-title":"Genetic ablation of tumor necrosis factor-alpha (TNF-alpha) and pharmacological inhibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum","volume":"89","author":"Ferger","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2011.09.171_bb0030","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neubiorev.2009.11.009","article-title":"Role of BDNF and GDNF in drug reward and relapse: a review","volume":"35","author":"Ghitza","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2011.09.171_bb0035","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10048-008-0137-1","article-title":"Nitric oxide synthase genes and their interactions with environmental factors in Parkinson's disease","volume":"9","author":"Hancock","year":"2008","journal-title":"Neurogenetics"},{"key":"10.1016\/j.ejphar.2011.09.171_bb0045","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson's disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejphar.2011.09.171_bb0040","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1749-6632.2003.tb07478.x","article-title":"The role of glial reaction and inflammation in Parkinson's disease","volume":"991","author":"Hirsch","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2011.09.171_bb0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1023\/A:1023863003093","article-title":"Role of dopamine transporter against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice","volume":"18","author":"Kurosaki","year":"2003","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ejphar.2011.09.171_bb0055","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/hmg\/ddg009","article-title":"Association between Parkinson's disease and polymorphisms in the nNOS and iNOS genes in a community-based case\u2013control study","volume":"12","author":"Levecque","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejphar.2011.09.171_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2008.08.053","article-title":"Phenidone protects the nigral dopaminergic neurons from LPS-induced neurotoxicity","volume":"445","author":"Li","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2011.09.171_bb0065","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0161-813X(01)00032-8","article-title":"Astrogliosis in the adult and developing CNS: is there a role for proinflammatory cytokines?","volume":"22","author":"Little","year":"2001","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.ejphar.2011.09.171_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.102.035048","article-title":"Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention","volume":"304","author":"Liu","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2011.09.171_bb0075","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0893-133X(01)00292-5","article-title":"The increase in TNF-alpha levels is implicated in NF-kappaB activation and inducible nitric oxide synthase expression in brain cortex after immnbilization stress","volume":"26","author":"Madrigal","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2011.09.171_bb0080","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","article-title":"Tumor necrosis factor-\u03b1 (TNF-\u03b1) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients","volume":"165","author":"Mogi","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2011.09.171_bb0085","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00702-009-0227-8","article-title":"Role of N-terminus of tyrosine hydroxylase in the biosynthesis of catecholamines","volume":"116","author":"Nakashima","year":"2009","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.ejphar.2011.09.171_bb0090","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1124\/jpet.105.097972","article-title":"Clozapine modulates aromatic L-amino acid decarboxylase activity in mouse striatum","volume":"317","author":"Neff","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2011.09.171_bb0095","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/jnr.20599","article-title":"Loss of dopaminergic neurons by the induction of inducible nitric oxide synthase and cyclooxygenase-2 via CD 40: relevance to Parkinson's disease","volume":"81","author":"Okuno","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ejphar.2011.09.171_bb0100","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1096\/fj.06-5864fje","article-title":"Developmental exposure to the pesticide dieldrin alters the dopamine system and increases neurotoxicity in an animal model of Parkinson's disease","volume":"20","author":"Richardson","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2011.09.171_bb0105","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1006\/exnr.1999.7296","article-title":"Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model","volume":"161","author":"Rosenbald","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2011.09.171_bb0110","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1021\/ar800201v","article-title":"Design of selective neuronal nitric oxide synthase inhibitors for the prevention and treatment of neurodegenerative diseases","volume":"42","author":"Silverman","year":"2009","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejphar.2011.09.171_bb0115","doi-asserted-by":"crossref","first-page":"6285","DOI":"10.3390\/molecules15096285","article-title":"Content of phenolic compounds and antioxidant capacity in fruits of apricot genotypes","volume":"15","author":"Sochor","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2011.09.171_bb0120","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2174\/187152809789352249","article-title":"Possible roles of microglial cells for neurotoxicity in clinical neurodegenerative diseases and experimental animal models","volume":"8","author":"Sugama","year":"2009","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"10.1016\/j.ejphar.2011.09.171_bb0125","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1021\/jf9001044","article-title":"Antioxidant phytochemicals and antioxidant capacity of biofortified carrots (Daucus carota L.) of various colors","volume":"57","author":"Sun","year":"2009","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejphar.2011.09.171_bb0130","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1096\/fj.04-2806fje","article-title":"Neuroprotective effects of (\u2212)-epigallocatechin gallate following hypoxia-ischemia-induced brain damage: novel mechanisms of action","volume":"19","author":"Sutherland","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2011.09.171_bb0135","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2741\/2713","article-title":"Neuroinflammation in Parkinson's disease: is there sufficient evidence for mechanism-based interventional therapy?","volume":"13","author":"Tansey","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.ejphar.2011.09.171_bb0140","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1073\/pnas.0837397100","article-title":"Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration","volume":"100","author":"Teismann","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2011.09.171_bb0145","doi-asserted-by":"crossref","first-page":"11510","DOI":"10.1021\/jf103258p","article-title":"Antioxidative and anti-inflammatory protection from carnosine in the striatum of MPTP-treated mice","volume":"58","author":"Tsai","year":"2010","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejphar.2011.09.171_bb0150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.abb.2008.03.011","article-title":"Peroxynitrite induced formation of the neurotoxins 5-S-cysteinyl-dopamine and DHBT-1: implications for Parkinson's disease and protection by polyphenols","volume":"476","author":"Vauzour","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2011.09.171_bb0155","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-2094-3-6","article-title":"Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease","volume":"3","author":"Vijitruth","year":"2006","journal-title":"Neuroinflammation"},{"key":"10.1016\/j.ejphar.2011.09.171_bb0160","first-page":"325","article-title":"Brain-IL-1 beta triggers astrogliosis through induction of IL-6: inhibition by propranolol and IL-10","volume":"10","author":"Woiciechowsky","year":"2004","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.ejphar.2011.09.171_bb0165","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1111\/j.1751-1097.2006.tb09829.x","article-title":"Suppressive effect of caffeic acid and its derivatives on the generation of UVA-induced reactive oxygen species in the skin of hairless mice and pharmacokinetic analysis on organ distribution of caffeic acid in ddY mice","volume":"82","author":"Yamada","year":"2006","journal-title":"Photochem. Photobiol."}],"updated-by":[{"DOI":"10.1016\/j.ejphar.2017.12.048","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,1,15]],"date-time":"2018-01-15T00:00:00Z","timestamp":1515974400000}}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991101154X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991101154X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:14:18Z","timestamp":1757974458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429991101154X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":33,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S001429991101154X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2011.09.171","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ejphar.2017.12.048","asserted-by":"object"}]},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preventive and therapeutic effects of caffeic acid against inflammatory injury in striatum of MPTP-treated mice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2011.09.171","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}